Refine
Year of publication
Document Type
- Preprint (706)
- Article (645)
- Book (2)
- Working Paper (2)
- Conference Proceeding (1)
- Part of Periodical (1)
Language
- English (1357)
Has Fulltext
- yes (1357)
Is part of the Bibliography
- no (1357)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron scattering (experiments) (12)
- Hadron-Hadron Scattering (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Genetics (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- CRISPR/Cas9 (3)
- Diffraction (3)
- Elastic scattering (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- Psychiatric disorders (3)
- Treatment (3)
- pp collisions (3)
- schizophrenia (3)
- ADHD (2)
- Beauty production (2)
- Biogeography (2)
- Bipolar disorder (2)
- Charm physics (2)
- Collectivity (2)
- Correlation (2)
- Elliptic flow (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Guidelines (2)
- HER2/neu (2)
- HLA class I (2)
- Heavy Ions (2)
- Heavy-ion collisions (2)
- Human behaviour (2)
- Immunology (2)
- Lepton-Nucleon Scattering (experiments) (2)
- MHC (2)
- Neuroscience (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Polarization (2)
- Quarkonium (2)
- RHIC (2)
- Shear viscosity (2)
- Single electrons (2)
- Sweden (2)
- Trauma (2)
- chemotherapy (2)
- epigenetics (2)
- 16S (1)
- 5-Aminolävulinsäure (5-ALA) (1)
- 5-aminolevulinic acid (5-ALA) (1)
- 900 GeV (1)
- ABC transporters (1)
- ALICE detector (1)
- APM (1)
- APP processing (1)
- ATAD2 (1)
- ATPases (1)
- Actin (1)
- Activities of daily living (1)
- Acute lymphocytic leukaemia (1)
- Adult (1)
- Adult-onset ADHD (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Aichi targets (1)
- Aiolochroia crassa (1)
- Alliaria petiolata (1)
- Alzheimer (1)
- Anti-nuclei (1)
- Antigens/Peptides/Epitopes (1)
- Antihormone therapy (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Appendectomy (1)
- Appendicitis (1)
- Arbitrage (1)
- Artificial Intelligence (1)
- Asymptotically Even Nonlinearity (1)
- Ataxia-telangiectasia (1)
- Atherosclerosis (1)
- Atmospheric chemistry (1)
- Atmospheric science (1)
- B-slope (1)
- BET inhibitors (1)
- BRCA1 (1)
- BRCA2 (1)
- BRD2 (1)
- BRD4 (1)
- BROMO-10 (1)
- BTC (1)
- Babesia divergens (1)
- Babesia microti (1)
- Big Five (1)
- Biochemistry and chemical biology (1)
- Biodiversity Data (1)
- Biodiversity conservation (1)
- Biodiversity tools and pipelines (1)
- Biological (1)
- Biomonitoring (1)
- Black and Scholes Option Price theory (1)
- Blocked Realized Kernel (1)
- Body temperature (1)
- Boosted Jets (1)
- Borrelia (1)
- Botanical Collections (1)
- Boundary Value Problems (1)
- Bromodomänen (1)
- CAR (1)
- CDH13 (1)
- CDK4/CDK6 (1)
- CNVs (1)
- COI (1)
- CVD biomarker (1)
- CVID (1)
- CYBA/p22phox (1)
- Cancer (1)
- Cancer genomics (1)
- Carbapenem-resistente Gram-negative Bakterien (CRGN) (1)
- Carbapenemasen (1)
- Cardiomyocyte signaling pathways (1)
- Cardiomyopathy (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Cardiovascular diseases (1)
- Cell biology (1)
- Cell membranes (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Chemische Sonden (1)
- Child health (1)
- Chronic hepatitis C (1)
- Circadian (1)
- Cirrhosis (1)
- Classification (1)
- Climate change (1)
- Clinical Trials and Observations (1)
- Clinical variation (1)
- Closure (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Community dynamics (1)
- Comorbidities (1)
- Comorbidity (1)
- Comparison with QCD (1)
- Complex I (1)
- Complicated appendicitis (1)
- Conformational trapping (1)
- Conservation (1)
- Conservative (1)
- Covariance Prediction (1)
- Critical point (1)
- CspA (1)
- CspZ (1)
- Cytoskeleton (1)
- DIPSHIFT (1)
- Data sharing (1)
- Data standard (1)
- Data standards (1)
- Database searching (1)
- Degenerate Linear Part (1)
- Depression (1)
- Deuteron production (1)
- Developmental trajectory (1)
- Di-hadron correlations (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Digitization (1)
- Dilated cardiomyopathy (1)
- Discovery (1)
- Disease Activity (1)
- Dissemination (1)
- Drug targeting (1)
- E. colo (1)
- E/I-Balance (1)
- EMT (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- Early Rheumatoid Arthritis (1)
- Ecology (1)
- Ecophysiology (1)
- Ed Diener (1)
- Elderly (1)
- Electron-pion identification (1)
- Electrophysiology (1)
- Electroweak interaction (1)
- Embolization (1)
- Ena/VASP proteins (1)
- Endothelial permeability (1)
- Entomology (1)
- Epigenetik (1)
- Epilepsy (1)
- Erythrocytes (1)
- European Society for Immunodeficiencies (ESID) (1)
- Extracellular RNA (eRNA) (1)
- Factor H (1)
- Factor Model (1)
- Femtoscopy (1)
- Ferroelectrics and multiferroics (1)
- Fibre/foam sandwich radiator (1)
- Fibromyalgia (1)
- Finite temperature field theory (1)
- Fistula (1)
- Flow (1)
- Forward physics (1)
- Frailty (1)
- G protein-coupled receptors (1)
- GWAS (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Gamma-Band Activity (1)
- General practitioners (1)
- German PID-NET registry (1)
- Germany (1)
- Giraffa (1)
- Groomed jet radius (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HBT (1)
- HEOR (1)
- HER2 c-erbB2 (1)
- HIV (1)
- HIV-1 (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Health risk analysis (1)
- Heart (1)
- Heart regeneration (1)
- Heart transplantation (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- Hepatitis C virus (1)
- Herbaria (1)
- Hereditary breast and ovarian cancer (1)
- Heregulin (1)
- Hif1α (1)
- Higher moments (1)
- Hippocampus (1)
- Human (1)
- Hypertension (1)
- IgA deficiency (1)
- IgG substitution therapy (1)
- Immunodeficiency (1)
- Immunogenetics (1)
- Immunoglobulins (1)
- Immunotherapy (1)
- In vitro selection (1)
- Inclusive spectra (1)
- Index at Infinity (1)
- Individual based modeling (1)
- Induced pluripotent stem cells (1)
- Inherited arrhythmic syndrome (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Ischemia–reperfusion injury (1)
- Isoxazoline Alkaloids (1)
- Italy (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- KCGS (1)
- Katze (1)
- Lactic acidosis (1)
- Landscape genetics (1)
- Landwirtschaftlicher Betrieb (1)
- Laparoscopic appendectomy (1)
- Laparostomy (1)
- Library screening (1)
- Lipid metabolism (1)
- Liver diseases (1)
- Liver transplantation (1)
- Long distance movement (1)
- Long-Range Dependence (1)
- Luciferase (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- Lymphopenia Mortality (1)
- MACE (1)
- MET (1)
- MM-121 (1)
- MRI (1)
- Magnetic properties and materials (1)
- Marine biodiversity (1)
- Material budget (1)
- Medizinische Chemie (1)
- Meldepflicht (1)
- Membrane protein (1)
- Mena/VASP (1)
- Mesh (1)
- Metaanalysis (1)
- Metastatic (1)
- MicroRNAs (miRNAs) (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mitochondria (1)
- Mitochondrial disorder (1)
- Mixing Frequencies (1)
- Mobile links (1)
- Molecular autopsy (1)
- Molecular biology (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- Myeloid Neoplasia (1)
- Myocardial infarction (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NK-92 (1)
- NMR (1)
- NO (1)
- Nanobody (1)
- Neolithic (1)
- Neonatal (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neural network (1)
- Nitric oxide (1)
- Non-operative (1)
- Non-trauma (1)
- Nonflow (1)
- Noninferiority (1)
- Nonperturbative effects in field theory (1)
- Nuclear modification factor (1)
- Nutrition (1)
- Oldest-old (1)
- Oncology (1)
- Open abdomen (1)
- OspE (1)
- Outcomes research (1)
- PARK2 (1)
- PDGFRβ (1)
- PID prevalence (1)
- PYTHIA (1)
- Pancreatitis (1)
- Parkinson's disease (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Pediatric (1)
- Peer review (1)
- Peritonitis (1)
- Personalized medicine (1)
- Phage display (1)
- Phase transitions and critical phenomena (1)
- Phosphorylation (1)
- Photodynamische Therapie (PDT) (1)
- Phylogenomics (1)
- Physiology (1)
- Platelet (1)
- Population genetics (1)
- Portfolio Optimization (1)
- Portfolios (1)
- Post-mortem genetic screening (1)
- Prediction (1)
- Predictive markers (1)
- Production Cross Section (1)
- Prognosis (1)
- Properties of Hadrons (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Psychiatry (1)
- QCD (1)
- Quantum field theory (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Questionnaires (1)
- RMS (1)
- Rapidity Range (1)
- Re-exploration (1)
- Red blood cell transfusion (1)
- Red blood cells (1)
- Reintervention (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Remote ischemic conditioning (1)
- Renal lesions (1)
- Research Article (1)
- Research Infrastructure (1)
- Resolution Parameter (1)
- Rheumatoid Arthritis (1)
- Ribosome display (1)
- SNP (1)
- STAR (1)
- SVR (1)
- Safety (1)
- Schizophrenia (1)
- Seasonal variation (1)
- Semantics (1)
- Seribantumab (1)
- Single muons (1)
- Small molecules (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Sozialverhalten (1)
- Species coexistence (1)
- Spectral Decomposition (1)
- Spectrin (1)
- Spin alignment (1)
- Spleen (1)
- Splitting function (1)
- Sponges (1)
- Stewardship (1)
- Stewardship and dissemination (1)
- Stochastic Analysis of Square Zero Variation Processes (1)
- Stroke (1)
- Structural biology and molecular biophysics (1)
- Structure Elucidation (1)
- Strukturbasiertes Design (1)
- Sudden cardiac death (1)
- Sudden death (1)
- Suicide (1)
- Sunlight (1)
- Surgery (1)
- Synaptic plasticity (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- Systematic reviews (1)
- T-DM1 (1)
- TGF-β (1)
- TR (1)
- Taxonomy (1)
- Technique (1)
- Thermal model (1)
- Tick-Borne diseases (1)
- Time Projection Chamber (1)
- Timing (1)
- Tools and pipelines (1)
- Tools and ressources (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trigger (1)
- Triple-negative breast cancer (1)
- Uncomplicated appendicitis (1)
- VEGF receptor 2 internalization and signaling (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- VUS (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Vesicles (1)
- Vitamin (1)
- Warzen (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- acute coronary syndromes (1)
- advanced breast cancer (1)
- agreeableness (1)
- algebraic cluster model (1)
- alirocumab (1)
- alleles (1)
- anaemia (1)
- anchialine cave (1)
- androgen receptor (1)
- anticoagulants (1)
- antigen presentation (1)
- antigen processing and presentation (1)
- antihormone therapy (1)
- antiseizure medication (1)
- atherosclerosis (1)
- atrial fibrillation (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- axions (1)
- azacitidine (1)
- binary nucleation (1)
- biobank (1)
- biogeographic legaciese (1)
- biomarkers (1)
- bioprinting (1)
- body-on-a-chip (1)
- bromodomain (1)
- bromodomain inhibitor (1)
- bromodomains (1)
- burden of illness (1)
- c-kit (1)
- cancer immunotherapy (1)
- carbapenem-resistant Gram-negative bacteria (CRGN) (1)
- carbapenemases (1)
- cardiocerebral resuscitation (1)
- cardiopulmonary resuscitation (1)
- cardiovascular disease (1)
- castration-resistant prostate cancer (1)
- cell-free expression (1)
- cellular therapy (1)
- chemical probes (1)
- chemogenomic set (1)
- child (1)
- children (1)
- chimeric antigen receptor (1)
- chromatin (1)
- chromium de novo assembly (1)
- citizen science (1)
- common genetic variation (1)
- complement (1)
- complexity (1)
- copy number polymorphism (1)
- cost containment (1)
- cross-linking (1)
- cryo-EM (1)
- cytokine-induced killer cells (1)
- cytotoxicity (1)
- dE/dx (1)
- dark matter experiments (1)
- demographic inference (1)
- detector (1)
- diagnosis (1)
- direct-acting antivirals (DAAs) (1)
- disease prevalence (1)
- domestication (1)
- drug discovery (1)
- druggable genome (1)
- dynamics (1)
- eNOS (1)
- early childhood (1)
- ectosomes (1)
- elderly patients (1)
- electrocardiography (1)
- endothelial cells (1)
- epigenetic (1)
- evolution (1)
- executive functions (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- follow-up (1)
- forest classification (1)
- forest functional similarity (1)
- functional connectivity (1)
- galunisertib monohydrate (LY2157299) (1)
- gastric cancer (1)
- gene flow (1)
- genes (1)
- genetic distance (1)
- genetic diversity (1)
- genetics (1)
- genome (1)
- genome-wide association study (1)
- genotype (1)
- genotype determination (1)
- giraffe (1)
- gliomas (1)
- global change (1)
- guidelines (1)
- habitat destruction (1)
- happiness (1)
- heart-on-a-chip (1)
- heavy ion experiments (1)
- hematopoietic stem cell transplantation (1)
- hemodialysis (1)
- host-pathogen interaction (1)
- human (1)
- human papilloma virus (HPV) (1)
- humanes Papillomvirus (HPV) (1)
- insertable cardiac monitor (1)
- inter-individual variability (1)
- ion‐induced nucleation (1)
- iron metabolism (1)
- juvenile myelomonocytic leukemia (1)
- kidney disease (1)
- kidney-on-a-chip (1)
- kinase inhibitor (1)
- knapsack cryptosystems (1)
- knockout (1)
- land use (1)
- lapatinib (1)
- lattice basis reduction (1)
- lattices (1)
- leukemia (1)
- leukopenia (1)
- life satisfaction (1)
- liver-on-a-chip (1)
- low-density lipoprotein cholesterol (1)
- lung-on-a-chip (1)
- macrophage polarization (1)
- magic angle spinning (1)
- magnetoencephalography (1)
- major adverse cardiovascular events (1)
- mandatory reporting system (1)
- medicinal chemistry (1)
- membrane proteins (1)
- mentalizing (1)
- metastatic (1)
- miRNA (1)
- micro-physiological systems (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- model system (1)
- molecular machines (1)
- multidrug-resistant Gram-negative bacteria (MRGN) (1)
- multiresistente Gram-negativen Stäbchenbakterien (MRGN) (1)
- multispecies coalescent (1)
- mutation (1)
- neural oscillations (1)
- neurodevelopment (1)
- neutropenia (1)
- next-generation sequencing (1)
- non-autonomous dynamical systems (1)
- nuclear collective model (1)
- obituary (1)
- obituary announcement (1)
- organs-on-a-chip (1)
- p+p collisions (1)
- pSMAD2 (1)
- pauli principle (1)
- perceptual closure (1)
- pericytes (1)
- pertuzumab (1)
- pharmacokinetics (1)
- phenotype (1)
- phenotypic screening (1)
- photodynamic therapy (PDT) (1)
- phylogenetic analysis (1)
- phylogenetic community distance (1)
- phylogenetic network (1)
- phylogeny (1)
- plant invasion (1)
- polymeric micelle (1)
- polymorphism (1)
- polypept(o)ide (1)
- population structure (1)
- positive psychology (1)
- precision weighting (1)
- predictive coding (1)
- primary active transporters (1)
- primary immunodeficiency (PID) (1)
- proprotein convertase subtilisin/kexin type 9 inhibition (1)
- prosocial behavior (1)
- protein kinase (1)
- quark gluon plasma (1)
- registry for primary immunodeficiency (1)
- reproducibility (1)
- research network (1)
- resistance-associated substitutions (RAS) (1)
- rhabdomyosarcoma (1)
- rigor (1)
- risk factor progression (1)
- risk factors (1)
- runs of homozygosity (1)
- seizures (1)
- sequence alignment (1)
- set-valued pullback attractors (1)
- single nucleotide polymorphism (1)
- single subject classification (1)
- skin-on-a-chip (1)
- small molecules (1)
- social exclusion (1)
- sofosbuvir (1)
- solar physics (1)
- speciation (1)
- spectra (1)
- sprouting angiogenesis (1)
- standardization (1)
- stroke prevention (1)
- structural biology (1)
- structure-based design (1)
- subjective well-being (1)
- subset sum problems (1)
- superparamagnetic iron oxide nanoparticles (1)
- surgery (1)
- switching systems (1)
- synaesthesia (1)
- temporal classification (1)
- theory of mind (1)
- tick (1)
- tip cell filopodia formation (1)
- topological entropy (1)
- trastuzumab (1)
- tropical forests (1)
- understudied kinase (1)
- velpatasvir (1)
- vessel-associated mural cells (1)
- voxilaprevir (1)
- warts (1)
- wassergefiltertes Infrarot A (wIRA) (1)
- waterfiltered infrared A (wIRA) (1)
- white and brown dwarfs (1)
- whole-genome sequencing (1)
- working memory (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1137)
- Frankfurt Institute for Advanced Studies (FIAS) (991)
- Informatik (910)
- Medizin (106)
- Geowissenschaften (15)
- Biochemie und Chemie (11)
- Biowissenschaften (11)
- Institut für Ökologie, Evolution und Diversität (7)
- Senckenbergische Naturforschende Gesellschaft (6)
- Biodiversität und Klima Forschungszentrum (BiK-F) (5)
The intense photon fluxes from relativistic nuclei provide an opportunity to study photonuclear interactions in ultraperipheral collisions. The measurement of coherently photoproduced π+π−π+π− final states in ultraperipheral Pb-Pb collisions at sNN−−−√=5.02 TeV is presented for the first time. The cross section, dσ/dy, times the branching ratio (ρ→π+π+π−π−) is found to be 47.8±2.3 (stat.)±7.7 (syst.) mb in the rapidity interval |y|<0.5. The invariant mass distribution is not well described with a single Breit-Wigner resonance. The production of two interfering resonances, ρ(1450) and ρ(1700), provides a good description of the data. The values of the masses (m) and widths (Γ) of the resonances extracted from the fit are m1=1385±14 (stat.)±3 (syst.) MeV/c2, Γ1=431±36 (stat.)±82 (syst.) MeV/c2, m2=1663±13 (stat.)±22 (syst.) MeV/c2 and Γ2=357±31 (stat.)±49 (syst.) MeV/c2, respectively. The measured cross sections times the branching ratios are compared to recent theoretical predictions.
The production cross section of inclusive isolated photons has been measured by the ALICE experiment at the CERN LHC in pp collisions at centre-of-momentum energy of s√=13 TeV collected during the LHC Run 2 data-taking period. The measurement is performed by combining the measurements of the electromagnetic calorimeter EMCal and the central tracking detectors ITS and TPC, covering a pseudorapidity range of |ηγ|<0.67 and a transverse momentum range of 7<pγT<200 GeV/c. The result extends to lower pγT and xγT=2pγT/s√ ranges, the lowest xγT of any isolated photon measurements to date, extending significantly those measured by the ATLAS and CMS experiments towards lower pγT at the same collision energy with a small overlap between the measurements. The measurement is compared with next-to-leading order perturbative QCD calculations and the results from the ATLAS and CMS experiments as well as with measurements at other collision energies. The measurement and theory prediction are in agreement with each other within the experimental and theoretical uncertainties.
The transverse momentum (pT) differential production cross section of the promptly-produced charm-strange baryon Ξ0c (and its charge conjugate Ξ0c¯¯¯¯¯¯) is measured at midrapidity via its hadronic decay into π+Ξ− in p−Pb collisions at a centre-of-mass energy per nucleon−nucleon collision sNN−−−√ = 5.02 TeV with the ALICE detector at the LHC. The Ξ0c nuclear modification factor (RpPb), calculated from the cross sections in pp and p−Pb collisions, is presented and compared with the RpPb of Λ+c baryons. The ratios between the pT-differential production cross section of Ξ0c baryons and those of D0 mesons and Λ+c baryons are also reported and compared with results at forward and backward rapidity from the LHCb Collaboration. The measurements of the production cross section of prompt Ξ0c baryons are compared with a model based on perturbative QCD calculations of charm-quark production cross sections, which includes only cold nuclear matter effects in p−Pb collisions, and underestimates the measurement by a factor of about 50. This discrepancy is reduced when the data is compared with a model in which hadronisation is implemented via quark coalescence. The pT-integrated cross section of prompt Ξ0c-baryon production at midrapidity extrapolated down to pT = 0 is also reported. These measurements offer insights and constraints for theoretical calculations of the hadronisation process. Additionally, they provide inputs for the calculation of the charm production cross section in p−Pb collisions at midrapidity.
Investigating strangeness enhancement with multiplicity in pp collisions using angular correlations
(2024)
A study of strange hadron production associated with hard scattering processes and with the underlying event is conducted to investigate the origin of the enhanced production of strange hadrons in small collision systems characterised by large charged-particle multiplicities. For this purpose, the production of the single-strange meson K0S and the double-strange baryon Ξ± is measured, in each event, in the azimuthal direction of the highest-pT particle (``trigger" particle), related to hard scattering processes, and in the direction transverse to it in azimuth, associated with the underlying event, in pp collisions at s√=5.02 TeV and s√=13 TeV using the ALICE detector at the LHC. The per-trigger yields of K0S and Ξ± are dominated by the transverse-to-leading production (i.e., in the direction transverse to the trigger particle), whose contribution relative to the toward-leading production is observed to increase with the event charged-particle multiplicity. The transverse-to-leading and the toward-leading Ξ±/K0S yield ratios increase with the multiplicity of charged particles, suggesting that strangeness enhancement with multiplicity is associated with both hard scattering processes and the underlying event. The relative production of Ξ± with respect to K0S is higher in transverse-to-leading processes over the whole multiplicity interval covered by the measurement. The K0S and Ξ± per-trigger yields and yield ratios are compared with predictions of three different phenomenological models, namely PYTHIA 8.2 with the Monash tune, PYTHIA 8.2 with ropes and EPOS LHC. The comparison shows that none of them can quantitatively describe either the transverse-to-leading or the toward-leading yields of K0S and Ξ±.
The first measurement of the impact-parameter dependent angular anisotropy in the decay of coherently photoproduced ρ0 mesons is presented. The ρ0 mesons are reconstructed through their decay into a pion pair. The measured anisotropy corresponds to the amplitude of the cos(2ϕ) modulation, where ϕ is the angle between the two vectors formed by the sum and the difference of the transverse momenta of the pions, respectively. The measurement was performed by the ALICE Collaboration at the LHC using data from ultraperipheral Pb−Pb collisions at a center-of-mass energy of sNN−−−√ = 5.02 TeV per nucleon pair. Different impact-parameter regions are selected by classifying the events in nuclear-breakup classes. The amplitude of the cos(2ϕ) modulation is found to increase by about one order of magnitude from large to small impact parameters. Theoretical calculations, which describe the measurement, explain the cos(2ϕ) anisotropy as the result of a quantum interference effect at the femtometer scale that arises from the ambiguity as to which of the nuclei is the source of the photon in the interaction.
Particle production as a function of charged-particle flattenicity in pp collisions at √s = 13 TeV
(2024)
This paper reports the first measurement of the transverse momentum (pT) spectra of primary charged pions, kaons, (anti)protons, and unidentified particles as a function of the charged-particle flattenicity in pp collisions at s√=13 TeV. Flattenicity is a novel event shape observable that is measured in the pseudorapidity intervals covered by the V0 detector, 2.8<η<5.1 and −3.7<η<−1.7. According to QCD-inspired phenomenological models, it shows sensitivity to multiparton interactions and is less affected by biases towards larger pT due to local multiplicity fluctuations in the V0 acceptance than multiplicity. The analysis is performed in minimum-bias (MB) as well as in high-multiplicity events up to pT=20 GeV/c. The event selection requires at least one charged particle produced in the pseudorapidity interval |η|<1. The measured pT distributions, average pT, kaon-to-pion and proton-to-pion particle ratios, presented in this paper, are compared to model calculations using PYTHIA 8 based on color strings and EPOS LHC. The modification of the pT-spectral shapes in low-flattenicity events that have large event activity with respect to those measured in MB events develops a pronounced peak at intermediate pT (2<pT<8 GeV/c), and approaches the vicinity of unity at higher pT. The results are qualitatively described by PYTHIA, and they show different behavior than those measured as a function of charged-particle multiplicity based on the V0M estimator.
Measurement of beauty production via non-prompt charm hadrons in p-Pb collisions at √sNN = 5.02 TeV
(2024)
The production cross sections of D0, D+, and Λ+c hadrons originating from beauty-hadron decays (i.e. non-prompt) were measured for the first time at midrapidity in proton−lead (p−Pb) collisions at the center-of-mass energy per nucleon pair of √sNN=5.02 TeV. Nuclear modification factors (RpPb) of non-prompt D0, D+, and Λ+c are calculated as a function of the transverse momentum (pT) to investigate the modification of the momentum spectra measured in p−Pb collisions with respect to those measured in proton−proton (pp) collisions at the same energy. The RpPb measurements are compatible with unity and with the measurements in the prompt charm sector, and do not show a significant pT dependence. The pT-integrated cross sections and pT-integrated RpPb of non-prompt D0 and D+ mesons are also computed by extrapolating the visible cross sections down to pT = 0. The non-prompt D-meson RpPb integrated over pT is compatible with unity and with model calculations implementing modification of the parton distribution functions of nucleons bound in nuclei with respect to free nucleons. The non-prompt Λ+c/D0 and D+/D0 production ratios are computed to investigate hadronisation mechanisms of beauty quarks into mesons and baryons. The measured ratios as a function of pT display a similar trend to that measured for charm hadrons in the same collision system.
The production yields of antideuterons and antiprotons are measured in pp collisions at a center-of-mass energy of √s=13 TeV, as a function of transverse momentum (pT) and rapidity (y), for the first time up to |y|=0.7. The measured spectra are used to study the pT and rapidity dependence of the coalescence parameter B2, which quantifies the coalescence probability of antideuterons. The pT and rapidity dependence of the obtained B2 is extrapolated for pT>1.7 GeV/c and |y|>0.7 using the phenomenological antideuteron production model implemented in PYTHIA 8.3 as well as a baryon coalescence afterburner model based on EPOS 3. Such measurements are of interest to the astrophysics community, since they can be used for the calculation of the flux of antinuclei from cosmic rays, in combination with coalescence models.
Stroke is a major public health issue worldwide. The prevalence of stroke in 2010 was 33 million, with 16.9 million people having a first stroke.1 Stroke was the second‐leading cause of death behind heart disease globally, accounting for over 10% of total deaths worldwide.
Stroke is a heterogeneous condition that can be due to rupture of a blood vessel (hemorrhagic) or to blockage of a vessel (ischemic). About 85% of strokes are ischemic in origin and these are often classified by mechanism. This should be distinguished from risk factors such as hypertension, diabetes, smoking, etc. Risk factors increase the risk of stroke but do not necessarily explain the mechanism of a particular stroke. About 25% of ischemic strokes have a radiographic appearance similar to that seen in patients with cardioembolic sources (such as atrial fibrillation [AF], prosthetic valves, valvular prolapse, or mitral valve regurgitation), but no embolic source is found. These "cryptogenic strokes" (CS; also called embolic strokes of undetermined source) pose a particular clinical challenge in that the optimal antithrombotic therapy to reduce recurrence is uncertain. Since there are currently no data to support long‐term oral anticoagulation (OAC) in CS, but also no specific trials that have addressed this question, guidelines recommend antiplatelet therapy. Identification of AF in these patients changes the most likely mechanism to cardioembolism, and thus changes the recommended antithrombotic therapy to OAC, which is extremely effective in preventing stroke in patients with AF.
This report is based on discussions held at The Diagnostics and Monitoring Stroke Focus Group, a meeting held on January 15 to 17, 2015. The meeting focused on CS as a healthcare issue, and the utility of extended cardiac monitoring for AF in patients with strokes of unknown origin. The objectives of the meeting were to review existing information on the subject, define areas where knowledge was lacking or limited, and discuss study designs by which information gaps might be filled.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.